Date of response: 28 April 2026

Outcome: Information disclosed

Category: Joint Commissioning and Planned Care

Request

Eligibility criteria for injectable weight loss medication

ICB Response

NN ICB 26 1560 Response Letter Final

pdf (254K)

Weight Loss Pathway Tirzepatide Interim Specification V3.0 (final)

pdf (926K)

Close
Search